| |
Research may allow breast cancer patietnt to keep hairBreast cancer news 3/8/2005 Florida Hospital Cancer Institute is conducting a new clinical research trial that would probably allow breast cancer patients to keep their hair. This trial includes a combination drug therapy of Herceptin and Bevacizumab. This trial involves biological agents and no chemotherapy, as per the researches. Florida Hospital Cancer Institute, in a prepared statement. If this proves to be effective, we will be able to offer patients effective therapy without the hair loss, nausea and vomiting, and other typical effects of cancer treatments. The trial is part of a relationship formed with the Florida Hospital Cancer Institute and University of California, Los Angeles that provides local cancer patients with some of the most effective cancer treatments available in the world. The Florida Hospital Cancer Institute is one of 32 international sites that works with the Translational Oncology Research International at UCLA in clinical research trials. The Translational Oncology Research International at UCLA and the Florida Hospital Cancer Institute currently are enrolling patients in six trials at Florida Hospital for patients with lung, breast and colorectal cancer. Many of the trials involve targeted therapy, which means that a medication or drug targets a specific pathway in the growth and development of a tumor. By attacking or blocking the targets, the therapy helps to fight the tumor itself. |